Who
Denice Torres
Director
Company insider
Files Form 4 as: Director, Celldex Therapeutics; Director, Glaukos; Director, Seaport Therapeutics; Director, 2seventy bio; Director, Karuna Therapeutics; Director, Surface Oncology; Director, bluebird bio.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 10 Aug 2020
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport TherapeuticsBiotechnology | SEC FORM 4 Code C | —13,406 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —42,105 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —42,105 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport TherapeuticsBiotechnology | SEC FORM 4 Code C | —13,406 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,258 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,258 at $0.00 | filing |
| 2 Jan 2026filed 7 Jan 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —623 at $0.00 | filing |
| 2 Jan 2026filed 7 Jan 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —623 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,149 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —2,108 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | 2seventy biooption or derivative | SEC FORM 4 Code D | —24,100 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.